March 18, 2019
New Orleans, Louisiana, USA: Data presented at the American College of Cardiology 68th Annual Scientific Session from Morristown Medical Center (Morristown, New Jersey), a leading U.S. academic medical center, showed the VasoStat™ Hemostasis Device produced hemostasis on average 34 minutes faster than the Terumo TR Band (Terumo Medical, Tokyo, Japan) among subjects undergoing diagnostic cardiac catheterization and percutaneous coronary intervention (PCI) using a transradial approach (P=0.038). This difference was even greater among subjects undergoing PCI, with a 43 minute reduction in time to hemostasis in favor of the VasoStat™ (P=0.045). All subjects in both study arms had their procedures performed through 6 French sheaths. No radial artery occlusion occurred among any of the VasoStat™ subjects. “We are excited that the differentiated technology of the VasoStat™, distinct from conventional balloon-type compression devices, safely and effectively produced hemostasis sooner in a randomized trial of real-world cardiac patients. With the growing trend toward same-day discharge among patients undergoing cardiac catheterization and PCI, such incremental benefits in time savings can significantly benefit patients, cath lab teams and facility workflow alike”, commented Timothy Clark, MD, CEO of Forge Medical.